Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BI-1808 by BioInvent International for Cutaneous T-Cell Lymphoma: Likelihood of Approval
BI-1808 is under clinical development by BioInvent International and currently in Phase II for Cutaneous T-Cell Lymphoma. According to GlobalData,...
BI-1808 by BioInvent International for T-Cell Lymphomas: Likelihood of Approval
BI-1808 is under clinical development by BioInvent International and currently in Phase II for T-Cell Lymphomas. According to GlobalData, Phase...
BI-1808 by BioInvent International for Gastrointestinal Stromal Tumor (GIST): Likelihood of Approval
BI-1808 is under clinical development by BioInvent International and currently in Phase II for Gastrointestinal Stromal Tumor (GIST). According to...
BI-1808 by BioInvent International for Melanoma: Likelihood of Approval
BI-1808 is under clinical development by BioInvent International and currently in Phase II for Melanoma. According to GlobalData, Phase II...